The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies
about
FASL rs763110 polymorphism contributes to cancer risk: an updated meta-analysis involving 43,295 subjectsDeath receptor (DR4) haplotypes are associated with increased susceptibility of gallbladder carcinoma in north Indian populationFunctional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese populationAnalysis of functional polymorphisms in apoptosis-related genes in primary open angle glaucomaBladder cancer epidemiology and genetic susceptibility.FasL gene -844T/C mutation of esophageal cancer in South China and its clinical significance.Functional polymorphisms in FAS, FASL and CASP8 genes and risk of childhood acute lymphoblastic leukemia: a case-control study.Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.Polymorphisms of the FAS and FASL genes and risk of breast cancer.Genetic polymorphisms in FAS (CD95) and FAS ligand (CD178) promoters and risk of tobacco-related oral carcinoma: gene-gene interactions in high-risk Indians.CD95 rs1800682 polymorphism and cervical cancer risk: evidence from a meta-analysis.Association between FAS and FASL genetic variants and risk of primary brain tumor.Associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis.Status of FAS and FAS Ligand Gene Polymorphisms in Patients with Breast Cancer in Northeastern IRAN
P2860
Q28389021-072BAAFD-ED35-48DB-9F95-7ABA614C920CQ28396733-A635C6BA-A8B7-418C-B345-566649C31D2CQ34551169-76833FDA-FD83-44CE-9762-776FDCFE18F9Q34950211-C4162297-897F-481C-A693-CE07DAB5791AQ36440524-EDAA00E4-6E0E-463F-AA52-B6E9922FFD87Q36878096-D42B5372-8851-4095-B93C-E2394C31637CQ37736549-6F0BD11F-8C23-4CB4-8042-995C5B41B6A7Q38435201-53DA2F26-19AA-4E2E-A90E-5AEE1BA058B4Q41759531-4D68BB96-3B3A-4514-8D0D-3BD5800D655EQ41811141-18F5F8D7-0D5F-4F69-883B-8CADCBCBFB71Q43522247-A8E6C694-4A4D-4F3A-A93A-C323E06D641DQ45387756-491860AE-EE13-4DE4-A33A-2B5B4CAA507AQ48957904-475E5C4A-060B-4CFE-A19D-CA1CC09474E1Q54389085-22574440-5088-4BD4-A251-B9AD9DB43EDEQ57489064-4F95A809-5685-4C4D-A02F-B872E653FB57
P2860
The FAS ligand promoter polymorphism, rs763110 (-844C>T), contributes to cancer susceptibility: evidence from 19 case-control studies
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The FAS ligand promoter polymo ...... e from 19 case-control studies
@ast
The FAS ligand promoter polymo ...... e from 19 case-control studies
@en
The FAS ligand promoter polymo ...... e from 19 case-control studies
@nl
type
label
The FAS ligand promoter polymo ...... e from 19 case-control studies
@ast
The FAS ligand promoter polymo ...... e from 19 case-control studies
@en
The FAS ligand promoter polymo ...... e from 19 case-control studies
@nl
prefLabel
The FAS ligand promoter polymo ...... e from 19 case-control studies
@ast
The FAS ligand promoter polymo ...... e from 19 case-control studies
@en
The FAS ligand promoter polymo ...... e from 19 case-control studies
@nl
P2093
P2860
P356
P1476
The FAS ligand promoter polymo ...... e from 19 case-control studies
@en
P2093
Meilin Wang
Zhengdong Zhang
Zhizhong Zhang
P2860
P2888
P304
P356
10.1038/EJHG.2009.45
P407
P577
2009-10-01T00:00:00Z